Visalytics
Visalytics
approved EB-2 (NIW)

Research Scientist

Biomedical Materials · China · 2025-08-20

Processing Time
180 days
Decision Date
2025-08-20
Location
Washington
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to continue research on biomolecular delivery vehicles to create novel drug delivery systems. This work focuses on enhancing drug targeting, controlled release, and bioavailability for the treatment of cancer and chronic diseases.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The research addresses cancer and chronic disease therapies, which are tied to U.S. healthcare innovation.

2 Well-positioned to Advance the Endeavor Met

The petitioner demonstrated readiness through a record of publications in top journals and significant citation metrics.

3 Balance of Factors Met

USCIS agreed that waiving the labor certification requirement would benefit the United States.

Why This Petition Was Approved

The petition was approved based on 4 peer-reviewed journal articles in top-ranked journals like Nano Letters, which accumulated 148 citations. The research received funding from major health institutes and satisfied all three Dhanasar prongs by demonstrating national importance in healthcare innovation.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Grants
Original Contributions
Government Alignment

Similar Cases

Postdoctoral Researcher

Chemicals · India

WeGreened EB-2 (NIW) approved
Massachusetts 156 days 2022-10-04
The petitioner proposes to continue research on developing state-of-the-art drug delivery approaches that cross biological interfaces. This work focuses on enabling the facile treatment of a wide range of disorders, including neurological disorders, metastatic cancer, and COVID-19, through protein-based therapies.
View Case

Scientist

Pharmaceuticals · China

WeGreened EB-2 (NIW) approved
New Jersey 51 days 2025-03-17
The petitioner proposes to develop novel and advanced drug delivery systems for new drug products to support animal studies and clinical trials across a wide scope of treatment indications. His work specifically focuses on improving the bioavailability, precision, and controlled release of medications to address the global burden of cardiovascular diseases (CVDs).
View Case

Scientist

Pharmaceuticals · India

WeGreened EB-2 (NIW) rfe approved
North Carolina 111 days 2025-02-08
The petitioner proposes to improve existing therapies by applying advanced pharmaceutical principles to commercialize biopharmaceuticals and pharmaceuticals. The work focuses on developing innovative drug solubility enhancement methods and non-invasive oral drug delivery systems to treat serious diseases like cancer, AIDS, and kidney failure.
View Case

Scientist

Pharmaceuticals · India

WeGreened EB-2 (NIW) approved
Massachusetts 13 days 2021-12-20
The petitioner proposes to develop safe and effective drug delivery platforms, including lipid-based nanoparticles, extracellular vesicles, oral biotherapeutics, and hydrogels. This work utilizes techniques such as microfluidics and high-performance liquid chromatography to facilitate improved targeting and dosage for treating rheumatoid arthritis, diabetes, and cancer.
View Case

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

More approved cases More Biotechnology cases More cases from China

Case data sourced from publicly available petition decisions and case studies. Decision date: 2025-08-20.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 180 days
Criteria Met 3 / 3
Evidence Types 5

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,813
Success Rate 53.7%
Sustained 2,046
Dismissed 1,671

Related Pages

EB-2 (NIW) Overview EB-2 (NIW) in China All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist